Docusign (NASDAQ:DOCU) Earns Hold (C) Rating from Weiss Ratings

Key Points

• Docusign's stock received a "hold (C)" rating from Weiss Ratings, affirming the current consensus rating of "Hold" with a price target of $94.14.
• The company's quarterly earnings surpassed expectations with $0.92 EPS, exceeding the consensus estimate by $0.08, and revenue increased by 8.8% year-over-year.
• Insider activity saw significant shares sold recently, with over $7.7 million worth of stock sold by insiders in the last 90 days, representing decreased ownership stakes.

Docusign (NASDAQ:DOCU - Get Free Report)'s stock had its "hold (c)" rating reaffirmed by equities researchers at Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.

DOCU has been the topic of a number of other reports. Piper Sandler raised their price target on shares of Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a research note on Friday, September 5th. Morgan Stanley lifted their price objective on shares of Docusign from $86.00 to $90.00 and gave the company an "equal weight" rating in a research note on Monday, September 8th. Wall Street Zen raised shares of Docusign from a "hold" rating to a "buy" rating in a report on Saturday, September 13th. JMP Securities reissued a "market outperform" rating and issued a $124.00 price target on shares of Docusign in a report on Friday, October 3rd. Finally, Citigroup boosted their price objective on Docusign from $110.00 to $115.00 and gave the company a "buy" rating in a research note on Thursday, September 4th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and fifteen have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $94.14.

Docusign Stock Up 2.3%

DOCU traded up $1.60 during trading hours on Wednesday, hitting $71.54. 2,672,304 shares of the company's stock were exchanged, compared to its average volume of 3,858,854. Docusign has a 1-year low of $66.35 and a 1-year high of $107.86. The stock's 50-day moving average is $75.68 and its two-hundred day moving average is $78.78. The stock has a market cap of $14.39 billion, a price-to-earnings ratio of 53.79, a PEG ratio of 3.48 and a beta of 1.02.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings results on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.08. The firm had revenue of $800.64 million for the quarter, compared to analyst estimates of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The company's quarterly revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, equities research analysts anticipate that Docusign will post 1.17 EPS for the current year.

Insider Activity at Docusign

In related news, insider James P. Shaughnessy sold 7,500 shares of the company's stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $71.19, for a total transaction of $533,925.00. Following the completion of the transaction, the insider owned 55,442 shares in the company, valued at $3,946,915.98. This represents a 11.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 9,509 shares of the company's stock in a transaction that occurred on Wednesday, September 17th. The shares were sold at an average price of $83.10, for a total value of $790,197.90. Following the transaction, the chief financial officer owned 112,160 shares of the company's stock, valued at approximately $9,320,496. This represents a 7.82% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 102,533 shares of company stock valued at $7,709,933 over the last 90 days. Company insiders own 1.01% of the company's stock.

Hedge Funds Weigh In On Docusign

Institutional investors have recently added to or reduced their stakes in the company. Oak Family Advisors LLC raised its holdings in Docusign by 37.2% in the second quarter. Oak Family Advisors LLC now owns 95,134 shares of the company's stock worth $7,410,000 after purchasing an additional 25,795 shares in the last quarter. New Age Alpha Advisors LLC raised its holdings in Docusign by 738.2% in the first quarter. New Age Alpha Advisors LLC now owns 41,187 shares of the company's stock worth $3,353,000 after purchasing an additional 36,273 shares in the last quarter. Pinpoint Asset Management Ltd raised its holdings in Docusign by 54.3% in the first quarter. Pinpoint Asset Management Ltd now owns 56,985 shares of the company's stock worth $4,639,000 after purchasing an additional 20,043 shares in the last quarter. Concurrent Investment Advisors LLC bought a new position in Docusign in the first quarter worth $618,000. Finally, Blair William & Co. IL raised its holdings in Docusign by 1.7% in the first quarter. Blair William & Co. IL now owns 387,542 shares of the company's stock worth $31,546,000 after purchasing an additional 6,460 shares in the last quarter. Institutional investors own 77.64% of the company's stock.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.